Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization

Background and Objectives: To assess the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin plus raltitrexed (HAICROX) as an alternative treatment option for advanced hepatocellular carcinoma (HCC) patients who are ineligible for, or failed, the transarterial chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanfang, Zheng, Susu, Zhang, Zhenzhen, Chen, Guobin, Chen, Xiaochun, Zheng, Tanghui, Guo, Xinkun, Chen, Hong, Wang, Meixia, Xie, Xiaoying, Zhang, Boheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607605/
https://www.ncbi.nlm.nih.gov/pubmed/36295504
http://dx.doi.org/10.3390/medicina58101343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607605/
https://www.ncbi.nlm.nih.gov/pubmed/36295504
http://dx.doi.org/10.3390/medicina58101343

Ejemplares similares